×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
知識庫
目錄總覽
文件總覽
最新討論
目錄 / 資料夾
學術活動與演講
年會
2025半年會
摘要
2024年會
摘要
2024半年會
摘要
2023年會
摘要
2023半年會
摘要
2022年會
摘要
2021年會
摘要
2021半年會
摘要
2020年會
摘要
2020半年會
摘要
2019年會
摘要
2019半年會
摘要
2018年會
摘要
2018半年會
摘要
2017年會
摘要
2017半年會
摘要
2016年會
摘要
2016半年會
摘要
2015年會
摘要
新手指南與FAQ
知識庫
最新上傳
最新上傳
(
熱門
)
最新上傳
(
熱門
)
MP04-07: Comparison of transperineal software-assisted fusion prostate biopsy and transperineal cognitive fusion prostate biopsy
06-11
MP04-06: The early oncological outcome of neoadjuvant androgen deprivation therapy before radical prostatectomy – a single-center experience and literature review
06-11
MP04-05: The prognostic value of biochemical markers in Radium-223 treated metastatic castration-resistant prostate cancer patients
06-11
MP04-04: Preoperative androgen deprivation therapy for radical prostatectomy and short-term oncological outcomes
06-11
MP04-03: Exploring healthcare policies: A comprehensive analysis of the 24-month medication restrictions for mHSPC
06-11
MP04-02: Preliminary single-hospital experience of androgen receptor pathway inhibitors for non-metastatic castration-resistant prostate cancer
06-11
MP04-01: Interim single-hospital experience of androgen receptor pathway inhibitors for metastatic hormone-sensitive prostate cancer
06-11
MP03-10: Adrenal vein sampling and its correlation with image and surgical outcome - a single-center cases series and literature review
06-11
MP03-09: Different treatment patterns and survival outcomes based on Cisplatin eligibility in patients with advanced urothelial carcinoma receiving first-line systemic therapy
06-11
MP03-08: Is neoadjuvant immune checkpoint inhibitors-base treatment beneficial to managements of locally advanced upper tract urothelial carcinoma (UTUC)?
06-11
MP03-07: Survival outcomes and clinical characteristics of variant histology in upper tract urothelial carcinoma
06-11
MP03-06: Analysis for bladder recurrence of upper tract urothelial carcinoma following radical nephroureterectomy with transurethral bladder cuff excision and pluck method
06-11
MP03-05: Development and validation of early recurrence predicting model in patients with localized upper tract urothelial carcinoma treated by radical nephroureterectomy
06-11
MP03-04: Long non-coding RNA OIP5-AS1 modulates upper tract urothelial carcinoma cell migration and invasion through regulating miR-340-5p/versican axis
06-11
MP03-03: Clinical effect of Denosumab in metastatic castration resistant prostate cancer – retrospective observational study
06-11
MP03-02: The impact of BMI on outcome of robotic-assisted radical prostatectomy: A single-center retrospective study
06-11
MP03-01: Real-world application of Darolutamide in non-metastatic castration-resistant prostate cancer in taiwan: A single-center experience
06-11
MP02-10: Predictive value of prostate urethral angle for the presence of prostatic surgical capsule calcification: A computed tomography-based study
06-11
MP02-09: Mobile extended reality applied in training of retrograde intrarenal surgery
06-11
MP02-08: Retrograde intrarenal surgery for upper urinary tract urolithiasis in pediatric patients –A single center experience
06-11
MP02-07: inflammation accelerated renal osteogenesis induced by calcium via MAPK pathway in the development of calcium phosphate stones
06-11
MP02-06: Percutaneous nephrolithotomy versus laparoscopic or open ureterolithotomy in the treatment of large proximal ureteral stone
06-11
MP02-05: Concurrent transurethral resection of the prostate (TURP) and inguinal hernioplasty
06-11
MP02-04: Can we predict bladder outlet obstruction in male patients with LUTS based on clinical symptoms and simple office-based diagnostic tools? Analysis of BOO risk score by IPSS V/S ratio, TPV, TZI, corrected Qmax and VUDS Results
06-11
<
2
3
4
5
6
7
8
9
10
11
>
/ 121